TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma
Science Advances · 2023
DOI: 10.1126/sciadv.ade8184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Akansha M Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Sarcoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Rhabdomyosarcoma (RMS) is a common soft tissue sarcoma in children that resembles developing skeletal muscle. Unlike normal muscle cells, RMS cells fail to differentiate despite expression of the myogenic determination protein MYOD. The TWIST2 transcription factor is frequently overexpressed in fusion-negative RMS (FN-RMS). TWIST2 blocks differentiation by inhibiting MYOD activity in myoblasts, but its role in FN-RMS pathogenesis is incompletely understood. Here, we show that knockdown of TWIST2 enables FN-RMS cells to exit the cell cycle and undergo terminal myogenesis. TWIST2 knockdown also substantially reduces tumor growth in a mouse xenograft model of FN-RMS. Mechanistically, TWIST2 controls H3K27 acetylation at distal enhancers by interacting with the chromatin remodelers SMARCA4 and CHD3 to activate growth-related target genes and repress myogenesis-related target genes. These findings provide insights into the role of TWIST2 in maintaining an undifferentiated and tumorigenic state of FN-RMS and highlight the potential of suppressing TWIST2-regulated pathways to treat FN-RMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
ORCID-Profile: Akansha M Shah, Priscilla Jaichander, Huocong Huang, Karla Cano Hernandez, Lin Xu, Rhonda Bassel-Duby, Eric N Olson, Ning Liu
Förderung
- NIAMS NIH HHS
Zitieren
APA
Shah, A. M., Guo, L., Morales, M. G., Jaichander, P., Chen, K., Huang, H., Cano Hernandez, K., Xu, L., Bassel-Duby, R., Olson, E. N., & Liu, N. (2023). TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Science Advances. https://doi.org/10.1126/sciadv.ade8184
Vancouver
Shah AM, Guo L, Morales MG, Jaichander P, Chen K, Huang H, et al. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Science Advances. 2023. doi:10.1126/sciadv.ade8184
BibTeX
@article{Shah2023,
author = {Shah, Akansha M and Guo, Lei and Morales, Maria Gabriela and Jaichander, Priscilla and Chen, Kenian and Huang, Huocong and Cano Hernandez, Karla and Xu, Lin and Bassel-Duby, Rhonda and Olson, Eric N and Liu, Ning},
title = {TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade8184}
}
EUVIMED